Goldman Sachs’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-719
| Closed | -$11.1K | – | 4978 |
|
|
2024
Q1 | $11.1K | Buy |
719
+31
| +5% | +$478 | ﹤0.01% | 4642 |
|
|
2023
Q4 | $9.5K | Sell |
688
-1
| -0.1% | -$14 | ﹤0.01% | 4651 |
|
|
2023
Q3 | $7.88K | Sell |
689
-6,678
| -91% | -$76.3K | ﹤0.01% | 4622 |
|
|
2023
Q2 | $183K | Buy |
7,367
+4,932
| +203% | +$123K | ﹤0.01% | 4423 |
|
|
2023
Q1 | $88.4K | Sell |
2,435
-26,917
| -92% | -$977K | ﹤0.01% | 4689 |
|
|
2022
Q4 | $1.77M | Sell |
29,352
-2,029
| -6% | -$122K | ﹤0.01% | 3356 |
|
|
2022
Q3 | $2.35M | Sell |
31,381
-534
| -2% | -$40.1K | ﹤0.01% | 3246 |
|
|
2022
Q2 | $3.66M | Sell |
31,915
-4,294
| -12% | -$492K | ﹤0.01% | 2943 |
|
|
2022
Q1 | $6.85M | Buy |
36,209
+6,393
| +21% | +$1.21M | ﹤0.01% | 2543 |
|
|
2021
Q4 | $10.3M | Buy |
29,816
+1,115
| +4% | +$387K | ﹤0.01% | 2241 |
|
|
2021
Q3 | $9.64M | Sell |
28,701
-4,022
| -12% | -$1.35M | ﹤0.01% | 2302 |
|
|
2021
Q2 | $27M | Buy |
+32,723
| New | +$27M | 0.01% | 1521 |
|